| 期刊簡介 | |||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | ONCOGENE LetPub Score 9.0
51 ratings
Rate
Reputation 9.7 Influence 8.5 Speed 8.3 | ||||||||||||||||||||||||||
| 期刊簡稱 | ONCOGENE | ||||||||||||||||||||||||||
| ISSN | 0950-9232 | ||||||||||||||||||||||||||
| E-ISSN | 1476-5594 | ||||||||||||||||||||||||||
| h-index | 312 | ||||||||||||||||||||||||||
| CiteScore |
| ||||||||||||||||||||||||||
| 自引率 (2023-2024) | 1.40%自引率趨勢 | ||||||||||||||||||||||||||
| 掲載範囲 |
| ||||||||||||||||||||||||||
| 官方網站 | https://www.nature.com/onc | ||||||||||||||||||||||||||
| 在線稿件提交 | https://mts-onc.nature.com/ | ||||||||||||||||||||||||||
| 開放訪問 | No | ||||||||||||||||||||||||||
| 出版商 | Springer Nature | ||||||||||||||||||||||||||
| 主題領域 | 医学 | ||||||||||||||||||||||||||
| 出版國/地區 | ENGLAND | ||||||||||||||||||||||||||
| 發行頻率 | 週刊 | ||||||||||||||||||||||||||
| 創刊年 | 1997 | ||||||||||||||||||||||||||
| 每年文章數 | 287每年文章數趨勢 | ||||||||||||||||||||||||||
| 黃金OA百分比 | 38.62% | ||||||||||||||||||||||||||
| Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q1
| ||||||||||||||||||||||||||
| 索引 (SCI or SCIE) | Science Citation Index Science Citation Index Expanded | ||||||||||||||||||||||||||
| 鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0950-9232%5BISSN%5D | ||||||||||||||||||||||||||
| 平均審稿時間 * | 來自出版商的數據: 來自作者的數據: About 1.0 month(s) | ||||||||||||||||||||||||||
| 競爭力 * | 來自作者的數據: About 31.25% | ||||||||||||||||||||||||||
| 參考鏈接 |
| ||||||||||||||||||||||||||
| *所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 | |||||||||||||||||||||||||||
|
|
| |
| 首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 | |
| [ONCOGENE] 的評論 | 撰寫評論 |
| 作者: Adelaide Lawson 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-12 10:35:24 評論於 The editorial department has made the final decision on the manuscript, but there may be some delay in the status update. Please pay close attention to any changes in status in the near future. |
| 作者: 通幽阉茂 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-12 08:08:07 評論於 The Editor in Chief's decision is finalized and it looks like it's not good. |
| 作者: 慈悲凝雨 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-11 13:58:42 評論於 May I ask what is your current status? |
| 作者: 杨家壬子 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-09-09 09:37:41 評論於 I also want to know. |
| 作者: Alston MacMillan 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-31 21:04:00 評論於 Is it under review now? How long have you been waiting in total? |
| 作者: 通幽阉茂 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-31 20:22:57 評論於 Submit successfully, good luck ahead. |
| 作者: 太山运珹 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-21 11:39:15 評論於 Can you please confirm if "Waiting for Potential Reviewer Assignment" means the manuscript is in the external review process? |
| 作者: Adelaide Lawson 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-21 11:11:37 評論於 The preliminary form review has been completed and the manuscript has officially entered the detailed evaluation stage for acceptance by the editor. |
| 作者: 断刀俊浩 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-21 10:39:49 評論於 Sharing my submission process, the relatively smooth first round of Stage Start Date Revision Received 23rd Jul 24 Waiting for Revision 21st Jun 24 Decision Made 21st Jun 24 Editor in Chief Decision Complete 19th Jun 24 Manuscript Decision complete 19th Jun 24 Editor Decision Complete 19th Jun 24 EIC Decision Started 19th Jun 24 Editor Review Completed 19th Jun 24 Receiving Editor Review Started 19th Jun 24 Review Complete 19th Jun 24 All Reviewers Assigned 6th Jun 24 Review Started 6th Jun 24 Under Consideration 29th May 24 Contacting Reviewers 29th May 24 Reviewers Assigned 29th May 24 Waiting for Potential Reviewer Assignment 21st May 24 Monitoring Editor Assigned 21st May 24 Potential Monitoring Editor Assigned 21st May 24 Under Consideration 21st May 24 Editor Assigned 17th May 24 Author Approved Converted Files 17th May 24 Submission 17th May 24 Second Round Revision Received 15th Aug 24 Waiting for Revision 14th Aug 24 Decision Made 14th Aug 24 Editor in Chief Decision Complete 10th Aug 24 Manuscript Decision complete 10th Aug 24 Editor Decision Complete 10th Aug 24 EIC Decision Started 9th Aug 24 Editor Review Completed 9th Aug 24 Receiving Editor Review Started 7th Aug 24 Review Complete 7th Aug 24 All Reviewers Assigned 29th Jul 24 Review Received 29th Jul 24 Review Started 29th Jul 24 First Reviewer Accepted 29th Jul 24 Potential Reviewers Accept 29th Jul 24 Contacting Reviewers 26th Jul 24 Reviewers Assigned 26th Jul 24 Waiting for Potential Reviewer Assignment 23rd Jul 24 Monitoring Editor Assigned 23rd Jul 24 Potential Monitoring Editor Accept 23rd Jul 24 Potential Monitoring Editor Assigned 23rd Jul 24 Editor Assigned 23rd Jul 24 Author Approved Converted Files 23rd Jul 24 Submission 23rd Jul 24 Third Round Decision Made 20th Aug 24 Editor in Chief Decision Complete 20th Aug 24 Manuscript Decision complete 20th Aug 24 Editor Decision Complete 20th Aug 24 Waiting for Potential Reviewer Assignment 20th Aug 24 Monitoring Editor Assigned 20th Aug 24 Potential Monitoring Editor Accept 20th Aug 24 Potential Monitoring Editor Assigned 20th Aug 24 Editor Assigned 15th Aug 24 Author Approved Converted Files 15th Aug 24 Submission 15th Aug 24 Overall, a very pleasant submission process with minimal need for additional experiments. The feedback from the two reviewers was positive and thorough. It seems that this journal has high standards for initial review, but the submission process was not too difficult after sending it in. Best wishes for successful submissions to everyone. |
| 作者: 断刀俊浩 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-18 13:37:41 評論於 Review Speed: 3.0 | Submission Hit Rate: 25.0 Experience Sharing: I will share my relatively smooth first round of submission process. Stage Start Date Revision Received 23rd Jul 24 Waiting for Revision 21st Jun 24 Decision Made 21st Jun 24 Editor in Chief Decision Complete 19th Jun 24 Manuscript Decision complete 19th Jun 24 Editor Decision Complete 19th Jun 24 EIC Decision Started 19th Jun 24 Editor Review Completed 19th Jun 24 Receiving Editor Review Started 19th Jun 24 Review Complete 19th Jun 24 All Reviewers Assigned 6th Jun 24 Review Started 6th Jun 24 Under Consideration 29th May 24 Contacting Reviewers 29th May 24 Reviewers Assigned 29th May 24 Waiting for Potential Reviewer Assignment 21st May 24 Monitoring Editor Assigned 21st May 24 Potential Monitoring Editor Assigned 21st May 24 Under Consideration 21st May 24 Editor Assigned 17th May 24 Author Approved Converted Files 17th May 24 Submission 17th May 24 Second Round Revision Received 15th Aug 24 Waiting for Revision 14th Aug 24 Decision Made 14th Aug 24 Editor in Chief Decision Complete 10th Aug 24 Manuscript Decision complete 10th Aug 24 Editor Decision Complete 10th Aug 24 EIC Decision Started 9th Aug 24 Editor Review Completed 9th Aug 24 Receiving Editor Review Started 7th Aug 24 Review Complete 7th Aug 24 All Reviewers Assigned 29th Jul 24 Review Received 29th Jul 24 Review Started 29th Jul 24 First Reviewer Accepted 29th Jul 24 Potential Reviewers Accept 29th Jul 24 Contacting Reviewers 26th Jul 24 Reviewers Assigned 26th Jul 24 Waiting for Potential Reviewer Assignment 23rd Jul 24 Monitoring Editor Assigned 23rd Jul 24 Potential Monitoring Editor Accept 23rd Jul 24 Potential Monitoring Editor Assigned 23rd Jul 24 Editor Assigned 23rd Jul 24 Author Approved Converted Files 23rd Jul 24 Submission 23rd Jul 24 Third Round Decision Made 20th Aug 24 Editor in Chief Decision Complete 20th Aug 24 Manuscript Decision complete 20th Aug 24 Editor Decision Complete 20th Aug 24 Waiting for Potential Reviewer Assignment 20th Aug 24 Monitoring Editor Assigned 20th Aug 24 Potential Monitoring Editor Accept 20th Aug 24 Potential Monitoring Editor Assigned 20th Aug 24 Editor Assigned 15th Aug 24 Author Approved Converted Files 15th Aug 24 Submission 15th Aug 24 Overall, it was a very pleasant submission experience, with almost no need for additional experiments. Both reviewers provided positive feedback, with the second one being very rigorous. It seems that this journal has high requirements for initial review, but it wasn't too difficult after submission. Best wishes to all for a successful submission. |
| 作者: 璃沙癸巳 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-16 10:09:56 評論於 It's been ten days already, time flies! Thank you, wish you good luck. |
| 作者: Zona Patrick 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-15 19:59:14 評論於 Three days later. |
| 作者: 璃沙癸巳 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-14 23:47:19 評論於 Excuse me, how long will you be online after you finish proofreading? |
| 作者: 璃沙癸巳 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-08-14 14:02:44 評論於 How long after your proof will you be online? |
| 作者: 猫巷少女普涵 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-07-26 11:16:59 評論於 Excuse me, do I have to pay for publishing in a non-OA model? After my article was published online, I received an invoice for payment, which has left me confused. Please clarify. |
| 作者: Adelaide Lawson 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-07-20 13:36:50 評論於 This stage has already passed the preliminary editing review and is now assigned to a processing editor who will begin a thorough review of your manuscript. |
| 作者: 元魁来了 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-07-18 19:07:13 評論於 Now it's not as good as the Cancer letter, let alone the JECCR. To be honest, they are not worthy of being in the top tier anymore. |
| 作者: 寂灭嘉荣 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-07-10 19:08:57 評論於 What stage is this Receiving Editor Review Started at? |
| 作者: 寂灭嘉荣 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-07-09 19:22:50 評論於 Research focus: Tumor experience sharing: What stage is this Receiving Editor Review Started at? |
| 作者: 乌龙驰皓 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-26 10:39:59 評論於 In the eyes of the old professor, applying for youth is one level higher than cancer letters, and their reputations were established long ago. It's hard to say what will happen in the future, but if you don't advance, you will regress, and oncogene has regressed significantly. |
| 作者: zzzmianyi 領域: 医学 審稿時間: 3.0 month(s) 結果: 修改後接受 撰寫評論 |
2024-06-26 01:29:44 評論於 Oh, the impact factor has decreased. |
| 作者: 是志丹吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-22 20:04:16 評論於 Please translate the following paragraph into English: Just write it clearly in the article, no need to consider the submission system itself. |
| 作者: 寂灭嘉荣 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-22 14:43:38 評論於 Just submitted a paper for external review, and the impact factor has dropped to below 7. How does this journal compare to Cancer Letters? |
| 作者: 是志丹吖 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-22 12:01:18 評論於 This is one reason, in addition to the fierce competition in tumor journals, there are too many new journals, Oncogene is a bit old, it is difficult to receive enough submissions, which is also the main reason. |
| 作者: 震雷博超 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2024-06-21 14:21:22 評論於 Research focus: oncology; Sharing of oncology experiences: Oncogene seems to never check the original data when submitting articles, leading to serious fraud, and the quality has significantly declined in recent years. Failure to make internal adjustments will lead to major problems. |
| 首頁 上一頁 1 2 3 4 5 6 7 下一頁 末頁 (頁 | |
Contact us